• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Land & Buildings Nominates Donna Brandin and Jonathan Litt for Election to the Board of Lexington Realty Trust

    12/6/21 8:00:00 AM ET
    $CAH
    $CLI
    $EQR
    $LXP
    Other Pharmaceuticals
    Health Care
    Real Estate Investment Trusts
    Consumer Services
    Get the next $CAH alert in real time by email

    Believes Nominees Have the Independent Perspectives, Differentiated Real Estate Investment Experience and Shareholder-Focused Mindsets Needed to Help Reverse Lexington's Chronic Underperformance

    Objective and Independent New Voices are Needed in the Boardroom to Oversee Leadership Transition Process and Full Review to Determine the Right Path Forward for LXP

    LXP's Total Shareholder Returns Have Underperformed Proxy Peers and Industrial Peers by Nearly 500% During CEO's 18-year Tenure1

    Today Land & Buildings Investment Management, LLC (together with its affiliates, "Land & Buildings"), a significant shareholder of Lexington Realty Trust ("LXP," "Lexington" or the "Company") (NYSE:LXP), announced its nomination of two highly-qualified and experienced candidates, Donna Brandin and Jonathan Litt, for election to the LXP Board of Trustees (the "Board") at the upcoming 2022 Annual Meeting of Shareholders (the "Annual Meeting").

    Ms. Brandin is the former Chief Financial Officer of Equity Residential (NYSE:EQR), the largest public owner and operator of apartments in the United States. She also previously served as the Chief Financial Officer of The Lightstone Group, LLC, a privately held real estate investment company, and currently serves as a director and as the Chair of the Audit Committee at Nuveen Global Cities Real Estate Investment Trust, a public non-traded real estate investment company sponsored by Teachers Insurance and Annuity Association of America.

    Mr. Litt is the Founder and Chief Investment Officer of Land & Buildings Investment Management, and previously was Managing Director and Senior Global Real Estate Analyst at Citigroup. Mr. Litt also previously served as a director on the Boards of Taubman Centers, Inc. (NYSE:TCO) and Mack-Cali Realty Corporation (NYSE:CLI).

    In connection with its nominations, Land & Buildings stated:

    "Lexington's track record of underperformance speaks volumes. During the 18-year tenure of CEO T. Wilson Eglin, the management team and the Board have consistently failed to close the discount between the Company's net asset value and its share price, or deliver shareholder returns on par with peers. Further, LXP's earnings have declined by 60% during the same period and its dividend has been reduced by over 60%2. Inexplicably, Mr. Eglin has been paid more than $65 million in total compensation for overseeing this value destruction3.

    Instead of working constructively to address the concerns we raised as shareholders, Lexington's Board has demonstrated a preference for gamesmanship and for a public proxy contest aimed at preserving the status quo. Unfortunately, history has given shareholders no reason to believe that keeping the current Board in place will result in anything besides more of the same disappointing results.

    It is clear that there is urgent need for real, shareholder-driven board change at Lexington. That is why we have nominated these two individuals, both of whom would bring differentiated real estate investment experience and objective and independent perspectives to the Company. In addition, Jon's appointment would ensure a true shareholder representative would be present to help oversee critical decisions regarding the best path forward for LXP – including the CEO succession process and the formation of a committee focused on evaluating the best pathways to create and maximize value."

    Additional Biographical Information on Nominees

    Donna Brandin
    previously served as Chief Financial Officer of Equity Residential (NYSE:EQR), a residential property real estate investment trust, and Executive Vice President, Chief Financial Officer and Treasurer of The Lightstone Group, LLC, a privately held real estate investment company, from 2008 to June 2018. Ms. Brandin currently serves as a director and as the Chair of the Audit Committee at Nuveen Global Cities Real Estate Investment Trust, a public non-traded real estate investment company sponsored by Teachers Insurance and Annuity Association of America, since January 2018. Ms. Brandin has also served as Executive Vice President and Chief Financial Officer of Eastern Generation, LLC (f/k/a US Power Generating Company), a power generation company, Executive Vice President and Senior Vice President and Treasurer at Cardinal Health Inc. (NYSE:CAH), a distributor of pharmaceuticals and other medical supplies. Ms. Brandin served as an advisory board member of eRESI Mortgage, LLC , a residential mortgage company sponsored by a Prominent New York Family Office, from November 2019 to October 2021 and she served as a director and Chairman of the Audit Committee at Invesque Inc. (TSX:IVQ), a real estate investment company, from July 2019 to May 2021. Ms. Brandin holds a Bachelor of Science degree in Business Administration from Kutztown University and a Master of Science degree in Finance from St. Louis University. She is a certified public accountant and recently completed the Harvard Business School Executive Education Corporate Directors Certification Program.

    Jonathan Litt is the Founder and Chief Investment Officer of Land & Buildings Investment Management, LLC, a registered investment advisor specializing in publicly traded real estate and real estate related securities, which he founded in 2008. Prior to founding L&B Management, Mr. Litt was Managing Director and Senior Global Real Estate Analyst at Citigroup, where he was responsible for Global Property Investment Strategy, coordinating a 44-person team of research analysts located across 16 countries. Mr. Litt previously served on the Board of Directors of Taubman Centers, Inc. (NYSE:TCO), a former S&P MidCap 400 Real Estate Investment Trust engaged in the ownership, management and/or leasing of regional, super-regional and outlet shopping centers in the U.S. and Asia, from May 2018 to May 2019. He has served as a director of the Land & Buildings Offshore Fund, Ltd. since 2008. Mr. Litt previously served as a director of Mack-Cali Realty Corporation (NYSE:CLI), a leading owner, manager, and developer of office and class A residential real estate throughout the Northeast, from March 2014 to August 2016, and as a director of the Children with Dyslexia Scholarship Fund. Mr. Litt holds a Bachelor of Arts degree in Economics from Columbia University and a Master of Finance degree from New York University's Stern School of Business.

    CERTAIN INFORMATION CONCERNING THE PARTICIPANTS

    Land & Buildings Investment Management, LLC together with the other participants named herein (collectively, "Land & Buildings"), intends to file a preliminary proxy statement and accompanying WHITE proxy card with the Securities and Exchange Commission ("SEC") to be used to solicit votes for the election of its slate of highly-qualified director nominees at the 2022 annual meeting of shareholders of Lexington Realty Trust, a Maryland corporation (the "Company").

    LAND & BUILDINGS STRONGLY ADVISES ALL SHAREHOLDERS OF THE COMPANY TO READ THE PROXY STATEMENT AND OTHER PROXY MATERIALS AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEB SITE AT HTTP://WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR.

    The participants in the proxy solicitation are anticipated to be Land & Buildings Capital Growth Fund, LP ("L&B Capital"), Land & Buildings GP LP ("L&B GP"), L&B Opportunity Fund, LLC ("L&B Opportunity"), Land & Buildings Investment Management, LLC ("L&B Management"), Jonathan Litt and Donna Brandin.

    As of the date hereof, L&B Capital directly owns 939,632 shares of common stock, par value $0.0001 per share, of the Company (the "Common Stock"). L&B GP, as the general partner of L&B Capital, may be deemed the beneficial owner of the 939,632 shares of Common Stock owned by L&B Capital. As of the date hereof, L&B Opportunity directly owns 147,736 shares of Common Stock. As of the date hereof, 3,475,399 shares of Common Stock were held in a certain account managed by L&B Management (the "Managed Account"). L&B Management, as the investment manager of each of L&B Capital and L&B Opportunity, and as the investment advisor of the Managed Account, may be deemed the beneficial owner of an aggregate of the 4,562,767 shares of Common Stock directly owned by L&B Capital, L&B Opportunity and held in the Managed Accounts. Mr. Litt, as the managing principal of L&B Management, may be deemed the beneficial owner of an aggregate of the 4,562,767 shares of Common Stock directly owned by L&B Capital, L&B Opportunity and held in the Managed Account. As of the date hereof, Ms. Brandin does not own any shares of Common Stock.

    _______________________________________________

    1
    Industrial Peers defined by Land & Buildings as STAG, MNR, PLD, DRE, FR, TRNO, REXR, EGP; Proxy Peers defined by the Company in its 2021 proxy statement (DEF 14A page 28) as competitor peer group EGP, EPRT, FR, GTY, NNN, OLP, PSB, REXR, STAG, STOR, TRNO, VER, WPC. Total shareholder returns through August 16, 2021, the day Land & Buildings' investment in LXP was disclosed in Form 13F.

    2 FFO growth based on 2021 consensus estimates from Bloomberg for current year and reported FFO as sourced by SEC filings and Bloomberg for prior years. Dividends based on expected full year 2021 regular cash dividends based on dividend run rates and prior year disclosed regular cash dividends.

    3 Based on Company Annual Proxy statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211206005189/en/

    Get the next $CAH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CAH
    $CLI
    $EQR
    $LXP

    CompanyDatePrice TargetRatingAnalyst
    Cardinal Health Inc.
    $CAH
    2/5/2025$140.00 → $150.00Hold → Buy
    Jefferies
    Cardinal Health Inc.
    $CAH
    1/8/2025$130.00 → $144.00Hold → Buy
    TD Cowen
    Cardinal Health Inc.
    $CAH
    1/7/2025$140.00In-line → Outperform
    Evercore ISI
    Cardinal Health Inc.
    $CAH
    1/6/2025$132.00 → $145.00Neutral → Buy
    BofA Securities
    Equity Residential
    $EQR
    12/17/2024$83.00Overweight
    Barclays
    Cardinal Health Inc.
    $CAH
    12/13/2024$101.00 → $127.00Underweight → Equal Weight
    Wells Fargo
    Cardinal Health Inc.
    $CAH
    12/4/2024$139.00Outperform
    Mizuho
    Equity Residential
    $EQR
    11/13/2024$77.75 → $81.50Hold → Buy
    Stifel
    More analyst ratings

    $CAH
    $CLI
    $EQR
    $LXP
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cardinal Health releases new report on the cell and gene therapy industry

      Analysis charts the emergence and future of advanced therapies DUBLIN, Ohio, May 7, 2025 /PRNewswire/ -- Today, Cardinal Health (NYSE:CAH) released its 2025 Advanced Therapies Report: Revolutionizing patient care – the promise and potential of cell and gene therapies, providing insights into the evolving landscape of cell and gene therapies (CGTs). This inaugural report is based on a comprehensive survey of more than 100 healthcare providers as well as interviews with subject matter experts and a patient who received CAR T-cell therapy, all of whom provide valuable insights in

      5/7/25 7:30:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an op

      5/5/25 5:30:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

      Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expirationGAAP1 operating earnings were $730 million; GAAP diluted EPS was $2.10Non-GAAP operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company's operating segments; non-GAAP diluted EPS increased 13% to $2.35Fiscal year 2025 non-GAAP EPS guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00GI Alliance announces expansion into urology specialty therapeutic areaDUBLIN, Ohio, May 1, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion,

      5/1/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $CLI
    $EQR
    $LXP
    Leadership Updates

    Live Leadership Updates

    See more
    • Robert Musslewhite and Sudhakar Ramakrishna to join Cardinal Health Board of Directors

      DUBLIN, Ohio, March 10, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors has elected Robert Musslewhite, former Chief Executive Officer of Definitive Healthcare Corp., and Sudhakar Ramakrishna, President and Chief Executive Officer of SolarWinds Corporation, as independent directors, effective March 7, 2025. With more than 20 years of leadership experience, including serving as CEO for two publicly traded companies, Mr. Musslewhite brings to the board unique expertise in advanced analytics, data, and technology across the healthcare e

      3/10/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • RPM Announces Appointment of Three New Board Members

      RPM International Inc. (NYSE:RPM) today announced the appointment of three individuals, Craig S. Morford, Christopher L. Mapes and Julie A. Beck, to its board of directors. These appointments reflect RPM's ongoing commitment to expanding the expertise, diversity and leadership capabilities of its board as the company continues to drive long-term growth and shareholder value. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250113146614/en/Christopher L. Mapes (Photo: Business Wire) The appointments of Mr. Morford and Mr. Mapes are effective immediately, and Ms. Beck's term is set to commence on April 7, 2025. With these additions,

      1/13/25 4:45:00 PM ET
      $AOS
      $CAH
      $LECO
      $NDSN
      Consumer Electronics/Appliances
      Consumer Discretionary
      Other Pharmaceuticals
      Health Care
    • Equity Residential Appoints Ann C. Hoff and Nina P. Jones to Board of Trustees

      Equity Residential (NYSE:EQR) today announced the appointment of Ann C. Hoff and Nina P. Jones to the Company's Board of Trustees to serve until the next annual meeting of shareholders. Both Ms. Hoff and Ms. Jones qualify as independent trustees under the New York Stock Exchange's listing standards. Ms. Hoff will serve on the Audit Committee and Ms. Jones will serve on both the Audit and Corporate Governance Committees. With these appointments, the Company's Board will increase to 11 members. Ms. Hoff, 57, is the President and Chief Operating Officer of Bellagio and Park MGM at MGM Resorts International (NYSE:MGM), a global gaming and entertainment company. In this role, which she has hel

      3/19/24 4:15:00 PM ET
      $EQR
      $MGM
      $SPG
      Real Estate Investment Trusts
      Real Estate
      Hotels/Resorts
      Consumer Discretionary

    $CAH
    $CLI
    $EQR
    $LXP
    Financials

    Live finance-specific insights

    See more
    • Cardinal Health Board of Directors Approves Quarterly Dividend

      DUBLIN, Ohio, May 5, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved an increase to its quarterly dividend, to $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2025, to shareholders of record at the close of business on July 1, 2025. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an op

      5/5/25 5:30:00 PM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health Reports Third Quarter Fiscal Year 2025 Results and Raises Fiscal Year 2025 Outlook

      Revenue was flat at $54.9 billion; revenue increased 19% excluding the impact of the previously communicated customer contract expirationGAAP1 operating earnings were $730 million; GAAP diluted EPS was $2.10Non-GAAP operating earnings increased 21% to $807 million, driven by segment profit growth across all of the company's operating segments; non-GAAP diluted EPS increased 13% to $2.35Fiscal year 2025 non-GAAP EPS guidance2 raised and narrowed to $8.05 to $8.15, from $7.85 to $8.00GI Alliance announces expansion into urology specialty therapeutic areaDUBLIN, Ohio, May 1, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2025 revenues of $54.9 billion,

      5/1/25 6:45:00 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • LXP Industrial Trust Reports First Quarter 2025 Results

      WEST PALM BEACH, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- LXP Industrial Trust ("LXP") (NYSE:LXP), a real estate investment trust focused on Class A warehouse and distribution real estate investments, today announced results for the quarter ended March 31, 2025. First Quarter 2025 Highlights Recorded Net Income attributable to common shareholders of $17.3 million, or $0.06 per diluted common share.Generated Adjusted Company Funds From Operations available to all equityholders - diluted ("Adjusted Company FFO") of $46.4 million, or $0.16 per diluted common share.Increased Same-Store NOI 5.2% compared to the same period in 2024.Completed 540,000 square foot lease extension, increasing the Ba

      5/1/25 6:00:00 AM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate

    $CAH
    $CLI
    $EQR
    $LXP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Equity Residential

      SC 13G/A - EQUITY RESIDENTIAL (0000906107) (Subject)

      11/14/24 1:22:34 PM ET
      $EQR
      Real Estate Investment Trusts
      Real Estate
    • Amendment: SEC Form SC 13G/A filed by LXP Industrial Trust

      SC 13G/A - LXP Industrial Trust (0000910108) (Subject)

      11/12/24 10:32:13 AM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate
    • SEC Form SC 13G filed by LXP Industrial Trust

      SC 13G - LXP Industrial Trust (0000910108) (Subject)

      11/1/24 3:48:58 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate

    $CAH
    $CLI
    $EQR
    $LXP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cardinal Health upgraded by Jefferies with a new price target

      Jefferies upgraded Cardinal Health from Hold to Buy and set a new price target of $150.00 from $140.00 previously

      2/5/25 7:09:45 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by TD Cowen with a new price target

      TD Cowen upgraded Cardinal Health from Hold to Buy and set a new price target of $144.00 from $130.00 previously

      1/8/25 7:36:58 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care
    • Cardinal Health upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Cardinal Health from In-line to Outperform and set a new price target of $140.00

      1/7/25 7:44:30 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care

    $CAH
    $CLI
    $EQR
    $LXP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP & Chief Financial Officer Garechana Robert bought $279 worth of Common Shares Of Beneficial Interest (4 units at $69.81), increasing direct ownership by 0.03% to 14,112 units (SEC Form 4)

      4 - EQUITY RESIDENTIAL (0000906107) (Issuer)

      3/26/25 4:10:10 PM ET
      $EQR
      Real Estate Investment Trusts
      Real Estate
    • Director Gupta Arun bought $134,250 worth of shares (15,000 units at $8.95), increasing direct ownership by 30% to 65,474 units (SEC Form 4)

      4 - LXP Industrial Trust (0000910108) (Issuer)

      6/14/24 4:03:37 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate

    $CAH
    $CLI
    $EQR
    $LXP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CAH
    $CLI
    $EQR
    $LXP
    SEC Filings

    See more
    • EVP & CHRO Carraway Catherine sold $71,044 worth of Common Shares Of Beneficial Interest (1,007 units at $70.55), decreasing direct ownership by 7% to 12,746 units (SEC Form 4)

      4 - EQUITY RESIDENTIAL (0000906107) (Issuer)

      5/5/25 4:14:55 PM ET
      $EQR
      Real Estate Investment Trusts
      Real Estate
    • Director Gray Lawrence L was granted 3,790 shares (SEC Form 4)

      4 - LXP Industrial Trust (0000910108) (Issuer)

      4/2/25 5:20:56 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate
    • Director Gupta Arun was granted 3,790 shares, increasing direct ownership by 5% to 78,934 units (SEC Form 4)

      4 - LXP Industrial Trust (0000910108) (Issuer)

      4/2/25 5:20:13 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate
    • LXP Industrial Trust filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - LXP Industrial Trust (0000910108) (Filer)

      5/1/25 12:39:29 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by LXP Industrial Trust

      10-Q - LXP Industrial Trust (0000910108) (Filer)

      5/1/25 12:34:05 PM ET
      $LXP
      Real Estate Investment Trusts
      Real Estate
    • SEC Form 10-Q filed by Cardinal Health Inc.

      10-Q - CARDINAL HEALTH INC (0000721371) (Filer)

      5/1/25 8:53:18 AM ET
      $CAH
      Other Pharmaceuticals
      Health Care